This is a clinical trial from Eastern Cooperative Thoracic Oncology Project (ECTOP), numbered as ECTOP-1023. This study aims to explore the safety and efficacy of primary lesion resection in the treatment of M1a stage lung cancer with pleural dissemination found during surgery, and to more accurately evaluate whether primary lesion resection can improve the OS and quality of life of the corresponding patients.
Study Type
OBSERVATIONAL
Enrollment
66
Fudan University Cancer Center
Shanghai, Shanghai Municipality, China
RECRUITINGMedian overall survival
Median overall survival for M1a patients underging surgery.
Time frame: About 10months.
2-year overall survival
2-year overall survival
Time frame: 2 years
5-year overall survival
5-year overall survival
Time frame: 5 years
FEV1 and FVC
Preoperative lung function test
Time frame: 0.5 year
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.